[go: up one dir, main page]

NO20015104D0 - Nytt farmasöytisk preparat - Google Patents

Nytt farmasöytisk preparat

Info

Publication number
NO20015104D0
NO20015104D0 NO20015104A NO20015104A NO20015104D0 NO 20015104 D0 NO20015104 D0 NO 20015104D0 NO 20015104 A NO20015104 A NO 20015104A NO 20015104 A NO20015104 A NO 20015104A NO 20015104 D0 NO20015104 D0 NO 20015104D0
Authority
NO
Norway
Prior art keywords
pharmaceutical preparation
new pharmaceutical
new
preparation
pharmaceutical
Prior art date
Application number
NO20015104A
Other languages
English (en)
Other versions
NO320609B1 (no
NO20015104L (no
Inventor
Paul David James Blackler
Robert Gordon Giles
Michael John Sasse
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20015104D0 publication Critical patent/NO20015104D0/no
Publication of NO20015104L publication Critical patent/NO20015104L/no
Publication of NO320609B1 publication Critical patent/NO320609B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NO20015104A 1999-04-20 2001-10-19 Hydroklorid-hydrat, anvendelse og fremstilling derav, samt farmasoytisk preparat. NO320609B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9909041.7A GB9909041D0 (en) 1999-04-20 1999-04-20 Novel pharmaceutical
PCT/GB2000/001521 WO2000063205A2 (en) 1999-04-20 2000-04-19 Thiazolidinedione derivative and its use as antidiabetic

Publications (3)

Publication Number Publication Date
NO20015104D0 true NO20015104D0 (no) 2001-10-19
NO20015104L NO20015104L (no) 2001-12-19
NO320609B1 NO320609B1 (no) 2005-12-27

Family

ID=10851901

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015104A NO320609B1 (no) 1999-04-20 2001-10-19 Hydroklorid-hydrat, anvendelse og fremstilling derav, samt farmasoytisk preparat.

Country Status (42)

Country Link
EP (2) EP1411055A1 (no)
JP (2) JP4283449B2 (no)
KR (1) KR100601244B1 (no)
CN (2) CN1327447A (no)
AP (1) AP1562A (no)
AR (2) AR023566A1 (no)
AT (1) ATE268770T1 (no)
AU (2) AU4130900A (no)
BG (1) BG65864B1 (no)
BR (1) BR0009897A (no)
CA (1) CA2382036A1 (no)
CO (1) CO5170422A1 (no)
CZ (1) CZ300653B6 (no)
DE (1) DE60011419T2 (no)
DK (1) DK1173436T3 (no)
DZ (1) DZ3162A1 (no)
EA (1) EA004232B1 (no)
EG (1) EG24063A (no)
ES (1) ES2218146T3 (no)
GB (1) GB9909041D0 (no)
HK (1) HK1045151B (no)
HR (1) HRP20010770B1 (no)
HU (1) HUP0200865A3 (no)
IL (1) IL146078A0 (no)
MA (1) MA26783A1 (no)
MX (1) MXPA01010696A (no)
MY (1) MY126034A (no)
NO (1) NO320609B1 (no)
NZ (1) NZ515166A (no)
OA (1) OA11866A (no)
PE (1) PE20010050A1 (no)
PL (1) PL351135A1 (no)
PT (1) PT1173436E (no)
RS (1) RS50136B (no)
SI (1) SI1173436T1 (no)
SK (1) SK284991B6 (no)
TR (1) TR200103040T2 (no)
TW (1) TWI277616B (no)
UA (1) UA71615C2 (no)
UY (1) UY26112A1 (no)
WO (1) WO2000063205A2 (no)
ZA (1) ZA200108720B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
SI1448559T1 (sl) * 2001-11-21 2007-06-30 Smithkline Beecham Plc 5-(4-(2-(n-metil-n-(2-piridil)amino)etoksi)benzil-tiazolidin-2,4-dion- benzensulfonat; postopek za njegovo pripravo; njegovi polimorfi i, ii, iii; in njegova uporaba kot farmacevtska uäśinkovina
GB0129872D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
CZ296468B6 (cs) * 2004-06-10 2006-03-15 Zentiva, A. S. Sul kyseliny fosforecné s 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dionema zpusob její prípravy
CZ296472B6 (cs) * 2004-07-27 2006-03-15 Zentiva, A. S Sul kyseliny stavelové s 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dionu azpusob její prípravy a její pouzití
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP1842850A1 (en) * 2006-03-23 2007-10-10 Sandoz AG Rosiglitazone hydrochloride hemihydrate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306228B1 (en) * 1987-09-04 1999-11-17 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
MY126034A (en) 2006-09-29
NZ515166A (en) 2004-02-27
NO320609B1 (no) 2005-12-27
NO20015104L (no) 2001-12-19
HK1045151B (en) 2005-03-18
OA11866A (en) 2006-03-02
DK1173436T3 (da) 2004-09-27
RS50136B (sr) 2009-03-25
BG65864B1 (bg) 2010-03-31
JP4283449B2 (ja) 2009-06-24
UY26112A1 (es) 2000-12-29
ES2218146T3 (es) 2004-11-16
HRP20010770A2 (en) 2002-10-31
AR023562A1 (es) 2002-09-04
AU2755202A (en) 2002-05-16
ATE268770T1 (de) 2004-06-15
AU765911B2 (en) 2003-10-02
BR0009897A (pt) 2002-04-16
ZA200108720B (en) 2002-11-28
DZ3162A1 (fr) 2000-10-26
CO5170422A1 (es) 2002-06-27
CA2382036A1 (en) 2000-10-26
HRP20010770B1 (en) 2005-06-30
HUP0200865A3 (en) 2005-04-28
WO2000063205A2 (en) 2000-10-26
UA71615C2 (uk) 2004-12-15
YU81501A (sh) 2004-07-15
AP2001002331A0 (en) 2000-04-19
AP1562A (en) 2006-02-01
HK1045151A1 (en) 2002-11-15
EP1173436A2 (en) 2002-01-23
SK284991B6 (sk) 2006-04-06
WO2000063205A3 (en) 2001-01-25
PT1173436E (pt) 2004-10-29
JP2009143954A (ja) 2009-07-02
EP1411055A1 (en) 2004-04-21
PL351135A1 (en) 2003-03-24
MXPA01010696A (es) 2002-06-04
HUP0200865A2 (en) 2002-08-28
JP2002542242A (ja) 2002-12-10
MA26783A1 (fr) 2004-12-20
SI1173436T1 (en) 2004-12-31
CN101134756A (zh) 2008-03-05
PE20010050A1 (es) 2001-03-10
CZ300653B6 (cs) 2009-07-08
EG24063A (en) 2008-05-08
EA004232B1 (ru) 2004-02-26
TR200103040T2 (tr) 2002-04-22
EA200101101A1 (ru) 2002-04-25
IL146078A0 (en) 2002-07-25
BG106112A (bg) 2002-05-31
KR20010110791A (ko) 2001-12-13
EP1173436B1 (en) 2004-06-09
TWI277616B (en) 2007-04-01
CZ20013759A3 (cs) 2002-05-15
KR100601244B1 (ko) 2006-07-19
AR023566A1 (es) 2002-09-04
DE60011419D1 (de) 2004-07-15
CN1327447A (zh) 2001-12-19
DE60011419T2 (de) 2005-06-16
AU4130900A (en) 2000-11-02
GB9909041D0 (en) 1999-06-16
SK14902001A3 (sk) 2002-02-05

Similar Documents

Publication Publication Date Title
NO20030418L (no) Nytt farmasöytisk preparat
NO20033143L (no) Farmasoytisk preparat
FI991485L (fi) Uusi farmaseuttinen koostumus
NO20005399D0 (no) Farmasøytisk preparat
NO20015175L (no) Farmasöytisk sammensetning
ATE392890T1 (de) Hydrogel-gesteuerte dosierungsform
FIU20000164U0 (fi) Uusi farmaseuttinen formulaatio
PT1242087E (pt) Composicoes farmaceuticas
NO20015149L (no) Nytt farmasöytisk preparat
EE200200150A (et) Preparaat
DK1466615T3 (da) Farmaceutisk præparat
NO20015670L (no) Forbedrede farmasöytiske formuleringer
NO20022606D0 (no) Farmasöytiske kombinasjoner
NO20025805D0 (no) Farmasöytisk preparat
NO20015148L (no) Nytt farmasöytisk preparat
NO20014926L (no) Farmasöytiske forbindelser
NO20015104L (no) Nytt farmasöytisk preparat
FI4488U1 (fi) Farmaseuttinen koostumus
NO20015105D0 (no) Nytt farmasöytisk preparat
AR025867A1 (es) Formulacion portasdora farmaceutica
NO20016430L (no) Farmasöytisk kompleks
NO20021036D0 (no) Farmasöytisk preparat
NO20004816D0 (no) Ny farmasøytisk formulering
NO20022541D0 (no) Fast preparat
NO20014450L (no) Farmasöytisk preparat basert på polyaromatiske forbindelser

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees